ADDENDUM   NCCAM EXPLORATORY/DEVELOPMENTAL GRANT FOR CLINICAL STUDIES 
(R21) PAR-03-153

RELEASE DATE:  February 5, 2004

NOTICE: NOT-CA-04-006

National Cancer Institute (NCI) 
 (http://www.nci.nih.gov)

This addendum is to inform potential applicants that the National 
Cancer Institute is co-sponsoring this announcement PAR-03-153 
(http://grants.nih.gov/grants/guide/pa-files/PAR-03-153.html) and is 
interested in research applications that focus on complementary and 
alternative medical approaches related to the prevention, diagnosis, 
and treatment of cancer as well as to the management of cancer symptoms 
and side effects due to conventional cancer treatment.

Applicants are encouraged to review the most recent NCI Plan and Budget 
Proposal for additional information about topics that are of program 
relevance to the NCI.  These documents are available at 
http://cancer.gov/publications, by email at [email protected], or 
by telephone at 1-800-4-CANCER and are published each year.  The 
document for fiscal 2004:  The Nation’s Investment in Cancer Research:  
A Plan and Budget Proposal for Fiscal Year 2004  is NIH Publication No. 
03-4373.

Applicants are also encouraged to review the topics that have been 
processed through the NCI’s Best Case Series program.  For additional 
information, see http://www.cancer.gov/cam or contact Dr. Wendy Smith 
(see below).

INQUIRIES

Inquiries regarding this notice may be directed to:

Wendy B. Smith, Ph.D.
Program Director, Research Development and Support Program
Office of Cancer Complementary and Alternative Medicine
National Cancer Institute
6130 Executive Blvd, EPN Suite 102, MSC 7302
Bethesda, Maryland 20892-7302
Rockville, MD 20852 (for express/courier service)
Telephone:  301-435-7980
FAX:  301-480-0075 
Email:  [email protected]

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

			Department of Health and Human Services (HHS)
NIH... Turning Discovery Into Health®